Stifel Financial’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-32,455
Closed -$57.1K 3551
2025
Q1
$57.1K Buy
32,455
+15,385
+90% +$35K ﹤0.01% 3342
2024
Q4
$45.4K Buy
17,070
+1,660
+11% +$4.27K ﹤0.01% 3320
2024
Q3
$35.3K Buy
15,410
+527
+4% +$1.61K ﹤0.01% 3318
2024
Q2
$43.5K Buy
14,883
+2,774
+23% +$8.46K ﹤0.01% 3288
2024
Q1
$44.1K Buy
+12,109
New +$23.3K ﹤0.01% 3264

Other funds holding NUVB

Stifel Financial's NUVB Position: Q2 2025 in Review

Stifel Financial sold out of Nuvation Bio (NUVB) in Q2 2025, closing a stake of 32,455 shares — an estimated $57.1K sold.

Stifel Financial first reported a position in NUVB in Q1 2024 and held it in 5 quarters. The position peaked at $57.1K in Q1 2025. 182 funds tracked by Wall St. Rank hold NUVB as of Q2 2025.

  • Stifel Financial reported no remaining Nuvation Bio position as of Q2 2025 after selling out during the quarter.
  • Stifel Financial sold 32,455 Nuvation Bio shares in Q2 2025, an estimated $57.1K.
  • Stifel Financial first reported a position in Nuvation Bio in Q1 2024 and held it in 5 quarters.
  • Stifel Financial's Nuvation Bio position peaked at $57.1K in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2025.

Based on Stifel Financial's 13F filing for Q2 2025, filed 14 Aug 2025.